Search for: "Precision Dose, Inc."
Results 41 - 60
of 94
Sort by Relevance
|
Sort by Date
25 Aug 2014, 9:35 am
Kirby Inland Marine Inc., 482 F.3d 347 (2007) (affirming the exclusion of Dr. [read post]
18 Jun 2014, 6:13 pm
Apple Inc., No. 12 Civ. 2826 (DLC), slip op. at 158 (S.D.N.Y. [read post]
15 Jun 2014, 10:36 am
The conflation of risk and (specific) causation is prevalent precisely because in many cases there is no scientific or medical way to discern what antecedent risks actually played a role in causing an individual’s disease. [read post]
1 Jun 2014, 7:45 am
CSX Transportation, Inc., No. 12-1135, 2012 WL 8899119 (Cir. [read post]
27 Feb 2014, 12:10 pm
Wellness Support Network, Inc., 2014 WL 644749, No. 10–cv–04879 (N.D. [read post]
21 Jan 2014, 8:22 am
AstenJohnson, Inc., No. 10-36142, 2014 WL 129884 (9th Cir. [read post]
4 Nov 2013, 9:08 am
Zimmer, Inc., 299 P.3d 463 (Okla. 2013), could be used to expand traditional tort causes of action under Oklahoma law in all sorts of novel and bizarre ways.Well, we still have that general concern, but if Clineis any indication, off-label use is not going to be one of those areas. [read post]
5 Sep 2013, 12:24 pm
Allergan, Inc., 863 F. [read post]
26 Aug 2013, 11:11 am
Some were randomly assigned to use e-cigs at either a steady dose of nicotine, a decreasing dose or no nicotine at all for 12 weeks. [read post]
5 Jun 2013, 5:29 am
Despite Greenland’s speculative objections, the concept of a doubling dose has been widely advocated by scientists. [read post]
23 May 2013, 5:00 am
Here, the emails themselves refuted agency, as they "criticized" what was being drafted (precisely why plaintiff wanted to use the emails). [read post]
5 Feb 2013, 11:32 am
Allergan Inc., 2013 U.S. [read post]
24 Nov 2012, 12:38 pm
If the other important Bradford Hill factors are present – dose-response, consistent, coherence, etc. [read post]
21 Nov 2012, 5:00 am
The plaintiff in Miller, therefore, tried to distinguish the case from those involving oral-dose formulations, which really just take issue with inherent risks associated with the API. [read post]
11 Sep 2012, 11:36 am
Genentech, Inc. [read post]
3 Jul 2012, 8:10 am
But the court, which tried to be precise elsewhere, appears to have lost its way in citing Iwatsubo here. [read post]
25 Jun 2012, 11:44 am
Approximation methods are often used, despite their lack of precision, because of their ease in calculation. [read post]
20 Jun 2012, 5:05 am
Inc. [read post]
29 May 2012, 10:06 am
Ony, Inc. v. [read post]
24 May 2012, 11:21 am
Inc, 506 A.2d 1100, 1108 (D.C 1986)(“[Dr. [read post]
